Literature DB >> 16309180

Reverse transcriptase-PCR analysis of apoptosis-regulating gene expression in human benign prostatic hyperplasia.

Cristiana Angelucci1, Fortunata Iacopino, Gina Lama, Giovanni Zelano, Giuseppe Gianesini, Gigliola Sica, Aldo Vittorio Bono.   

Abstract

BACKGROUND: To determine whether an imbalanced interaction between proapototic and antiapoptotic signals may account for the loss of the normal cell growth control in benign prostatic hyperplasia (BPH), the expression of some apoptosis-regulating genes (bcl-2, bax, c-myc, fas) was investigated. PATIENTS AND METHODS: BPH specimens were obtained from 20 patients who underwent trans-urethral resection of the prostate (TURP) or adenomectomy. Gene expression was studied by reverse transcriptase-polymerase chain reaction (RT-PCR) and its correlation with age and serum PSA level was also investigated.
RESULTS: Genes were found to be differentially expressed in BPH tissues. In particular, the antiapoptotic gene bcl-2, which was found in 18/20 samples, gave the weakest signal (p < 0.05 - p < 0.001, Wilcoxon's signed rank test), whereas the cell cycle regulator c-myc was detected in all the specimens and was the most highly expressed (p < 0.001). A positive relationship between the expression of bcl-2 and that of the two proapoptotic genes bax and fas was observed (p < 0.05, Spearman's rank correlation test), as well as between c-myc and fas levels (p < 0.005). Moreover, bax expression positively correlated with age and PSA (p < 0.02), which have also been shown to directly correlate (p < 0.01).
CONCLUSION: The higher expression of the oncogene c-myc suggests the activation of mitogenic signals within hyperplastic prostate tissue which a relatively high expression of the proapoptotic genes bax and fas fails to counterbalance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309180

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Qianliening capsule () inhibits human prostate cell growth via induction of mitochondrion-dependent cell apoptosis.

Authors:  Zhen-Feng Hong; Jiu-Mao Lin; Xiao-Yong Zhong; Ying Li; Jian-Heng Zhou; Wei Xu; Jun Peng
Journal:  Chin J Integr Med       Date:  2012-10-20       Impact factor: 1.978

2.  miRNA Regulation Network Analysis in Qianliening Capsule Treatment of Benign Prostatic Hyperplasia.

Authors:  Liya Liu; Yun Wan; Aling Shen; Jinyan Zhao; Jiumao Lin; Xiaoyong Zhong; Yuchen Zhang; Zhenfeng Hong
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-30       Impact factor: 2.629

Review 3.  Apoptotic Pathways Linked to Endocrine System as Potential Therapeutic Targets for Benign Prostatic Hyperplasia.

Authors:  Letteria Minutoli; Mariagrazia Rinaldi; Herbert Marini; Natasha Irrera; Giovanni Crea; Cesare Lorenzini; Domenico Puzzolo; Andrea Valenti; Antonina Pisani; Elena B Adamo; Domenica Altavilla; Francesco Squadrito; Antonio Micali
Journal:  Int J Mol Sci       Date:  2016-08-11       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.